Clinical Trial Update: Cavilon Breast Trial: Comparison of Cavilon Durable Barrier Cream to Glycerine ("Sorbolene") Cream [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Cavilon Durable Barrier Cream with Sorbolene (glycerin-based) cream in breast cancer patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Cavilon Durable Barrier Cream
• Sorbolene Cream (glycerin-based moisturizing cream)

Snippet

Sponsor: Trans Tasman Radiation Oncology Group | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED